Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immune profile and platelet function changes after starting eltrombopag in chronic ITP
NL-OMON55371Active, not recruiting
- Sponsor
- University Medical Center Utrecht
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of eltrombopag in immune thrombocytopenia (ITP), sponsored by University Medical Center Utrecht. Primary endpoints: Changes in B-cell and T-cell profiles and Changes in platelet function and reactivity. Started Dec 2019; status: active, not recruiting.
02
Drugs
eltrombopag
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on NL-OMON55371.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON55371.